Kastury Medicament Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.20 M
- Company Age 6 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.00 M
- Revenue Growth 3.69%
- Profit Growth 4.25%
- Ebitda 9.96%
- Net Worth 7.34%
- Total Assets 2.35%
About Kastury Medicament
Kastury Medicament Private Limited (KMPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 May 2018 (Six years and eight months 16 days old ). Its registered office is in Ranchi, Jharkhand, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.20 M.
The company currently has active open charges totaling ₹1.00 M.
Chandan Tiwary and Kundan Tiwari serve as directors at the Company.
Company Details
- Location
Ranchi, Jharkhand, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U74999JH2018PTC011402
- Company No.
011402
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 May 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Jharkhand
Industry
Who are the key members and board of directors at Kastury Medicament?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chandan Tiwary  | Director | 17-May-2018 | Current |
| Kundan Tiwari | Director | 17-May-2018 | Current |
Financial Performance of Kastury Medicament.
Kastury Medicament Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 3.69% increase. The company also saw a slight improvement in profitability, with a 4.25% increase in profit. The company's net worth moved up by a moderate rise of 7.34%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kastury Medicament?
In 2019, Kastury Medicament had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Aspen Enggicon Private LimitedChandan Tiwary and Kundan Tiwari are mutual person
Desaenergy Private LimitedChandan Tiwary is a mutual person
- Shubhyog Event Solutions Private Limited
Chandan Tiwary is a mutual person
- Ram Lakhan Shiv Puri Eduworld Foundation
Chandan Tiwary is a mutual person
Charges (Loans)
₹1.00 M
₹0
Charges Breakdown by Lending Institutions
- Indian Bank : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Aug 2023 | Indian Bank | ₹1.00 M | Open |
How Many Employees Work at Kastury Medicament?
Unlock and access historical data on people associated with Kastury Medicament, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kastury Medicament, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kastury Medicament's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.